Niels Neymark

917 total citations
21 papers, 640 citations indexed

About

Niels Neymark is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Niels Neymark has authored 21 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Niels Neymark's work include Health Systems, Economic Evaluations, Quality of Life (12 papers), Economic and Financial Impacts of Cancer (7 papers) and Healthcare Policy and Management (4 papers). Niels Neymark is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (12 papers), Economic and Financial Impacts of Cancer (7 papers) and Healthcare Policy and Management (4 papers). Niels Neymark collaborates with scholars based in Belgium, Netherlands and United Kingdom. Niels Neymark's co-authors include Egbert F. Smit, P. Lianes, Bonne Biesma, C. Debruyne, Catherine Legrand, Franz M.N.H. Schramel, Giuseppe Giaccone, C. Manegold, Hans J.M. Smit and Rabab Gaafar and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Urology.

In The Last Decade

Niels Neymark

21 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niels Neymark Belgium 11 397 352 112 92 71 21 640
Frédéric Fiteni France 14 266 0.7× 346 1.0× 133 1.2× 108 1.2× 37 0.5× 41 611
Francovito Piantedosi Italy 7 472 1.2× 507 1.4× 70 0.6× 67 0.7× 23 0.3× 12 774
Christophe Desauw France 8 209 0.5× 305 0.9× 141 1.3× 64 0.7× 35 0.5× 27 603
Assaf Moore Israel 15 277 0.7× 339 1.0× 148 1.3× 62 0.7× 88 1.2× 52 653
Eric T. Lubiner United States 5 244 0.6× 422 1.2× 85 0.8× 143 1.6× 42 0.6× 9 858
Arti Parekh United States 13 415 1.0× 281 0.8× 139 1.2× 40 0.4× 117 1.6× 19 792
Guy de Laroche France 12 199 0.5× 206 0.6× 127 1.1× 60 0.7× 41 0.6× 43 519
Juliane Lungershausen Germany 10 530 1.3× 466 1.3× 90 0.8× 100 1.1× 30 0.4× 20 802
I. Boler United States 5 219 0.6× 388 1.1× 83 0.7× 145 1.6× 41 0.6× 8 832
H. Le Caer France 13 555 1.4× 523 1.5× 133 1.2× 25 0.3× 41 0.6× 49 819

Countries citing papers authored by Niels Neymark

Since Specialization
Citations

This map shows the geographic impact of Niels Neymark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niels Neymark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niels Neymark more than expected).

Fields of papers citing papers by Niels Neymark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niels Neymark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niels Neymark. The network helps show where Niels Neymark may publish in the future.

Co-authorship network of co-authors of Niels Neymark

This figure shows the co-authorship network connecting the top 25 collaborators of Niels Neymark. A scholar is included among the top collaborators of Niels Neymark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niels Neymark. Niels Neymark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Neymark, Niels, P. Lianes, Egbert F. Smit, & Jan P. van Meerbeeck. (2005). Economic Evaluation of Three Two-Drug Chemotherapy Regimens in Advanced Non-Small-Cell Lung Cancer. PharmacoEconomics. 23(11). 1155–1166. 14 indexed citations
3.
4.
5.
6.
Crott, Ralph & Niels Neymark. (2002). Health Economics Unit achievements. European Journal of Cancer. 38. 147–150. 1 indexed citations
7.
Neymark, Niels, et al.. (2002). Cost Effectiveness of Paclitaxel/Cisplatin Compared with Cyclophosphamide/Cisplatin in the Treatment of Advanced Ovarian Cancer in Belgium. PharmacoEconomics. 20(7). 485–497. 18 indexed citations
8.
Neymark, Niels, et al.. (2001). Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer. European Journal of Cancer. 37(14). 1768–1774. 16 indexed citations
9.
Neymark, Niels. (2001). Assessment of the economic value of epoetin use in anemic cancer patients. Expert Review of Pharmacoeconomics & Outcomes Research. 1(2). 167–175. 1 indexed citations
10.
Neymark, Niels & Giovanni Rosti. (2000). Patient management strategies and transplantation techniques in european stem cell transplantation centers offering breast cancer patients high-dose chemotherapy with peripheral blood stem cell support: a joint report from the EORTC and EBMT.. PubMed. 85(7). 733–44. 7 indexed citations
11.
Neymark, Niels. (1999). Techniques for health economics analysis in oncology: part 2. Critical Reviews in Oncology/Hematology. 30(1). 13–24. 7 indexed citations
12.
Neymark, Niels, et al.. (1999). The costs of managing patients with advanced colorectal cancer in 10 different European centres. European Journal of Cancer. 35(13). 1789–1795. 16 indexed citations
13.
Neymark, Niels. (1999). Techniques for health economics analysis in oncology: part 1. Critical Reviews in Oncology/Hematology. 30(1). 1–11. 5 indexed citations
14.
Grégoire, Vincent, Marc Hamoir, Jean-François Rosier, et al.. (1999). Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy. Radiotherapy and Oncology. 53(1). 1–13. 32 indexed citations
15.
Neymark, Niels. (1998). Assessing the economic value of anti-cancer therapies. Springer eBooks. 3 indexed citations
16.
Neymark, Niels. (1998). First European conference on the economics of cancer. European Journal of Cancer. 34(6). 809–809. 1 indexed citations
17.
Neymark, Niels, Linda Davies, Peter Fayers, et al.. (1998). Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop. European Journal of Cancer. 34(9). 1317–1333. 41 indexed citations
18.
Neymark, Niels. (1998). Critical reviews of economic analyses in order to make health care decisions for cancer. Annals of Oncology. 9(11). 1167–1172. 6 indexed citations
19.
Neymark, Niels. (1998). Assessing the Economic Value of Anticancer Therapies. Recent results in cancer research. 148. 1–285. 21 indexed citations
20.
Neymark, Niels & Koen Torfs. (1997). Economics of Urinary TractCancers: State of the Art. European Urology. 31(1). 72–81. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frédéric Fiteni Breakdown of academic impact, for papers by Francovito Piantedosi Breakdown of academic impact, for papers by Christophe Desauw Breakdown of academic impact, for papers by Assaf Moore Breakdown of academic impact, for papers by Eric T. Lubiner Breakdown of academic impact, for papers by Arti Parekh Breakdown of academic impact, for papers by Guy de Laroche Breakdown of academic impact, for papers by Juliane Lungershausen Breakdown of academic impact, for papers by I. Boler Breakdown of academic impact, for papers by H. Le Caer
Rankless by CCL
2026